person

Gianluca G.

Country
Italy
Department
SCDU Ematologia

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
170
Sites with multiple studies

Has run more than one trial at 170 of 343 partner sites.

Specializations

Chronic Lymphocytic Leukemia Research

The investigator specializes in treating chronic lymphocytic leukemia (CLL), with particular emphasis on novel therapeutic combinations. Their research encompasses both previously untreated CLL and cases with genetic variations including TP53 mutations.

  • BTK Inhibitor Therapies
  • Venetoclax-Based Combinations
  • Targeted Treatment Approaches

Their work includes evaluating treatment responses through minimal residual disease assessment and exploring personalized treatment strategies.

Diffuse Large B-Cell Lymphoma Studies

The investigator conducts extensive research in diffuse large B-cell lymphoma (DLBCL), focusing on both newly diagnosed and relapsed/refractory cases. Their work includes investigating novel therapeutic combinations and treatment strategies.

  • Immunochemotherapy Optimization
  • Novel Agent Integration
  • Treatment Response Assessment

Particular attention is given to specific DLBCL subtypes and molecular profiles, including ABC-DLBCL.

Advanced Lymphoma Management

The investigator's expertise extends to various lymphoma subtypes, including mantle cell lymphoma and follicular lymphoma. Their research encompasses innovative treatment approaches for both initial therapy and relapsed disease.

  • Novel Therapeutic Combinations
  • Maintenance Strategies
  • Treatment Resistance Management

Focus areas include developing strategies for patients ineligible for stem cell transplantation and exploring new targeted therapies.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.